Perspective on this Article from Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR-Mutant Cells
Authors:
- Jie ZhangJZJie Zhang
- Kentaro IwanagaKIKentaro Iwanaga
- Kuicheon C. ChoiKCKuicheon C. Choi
- Marie WislezMWMarie Wislez
- Maria Gabriela RasoMaria Gabriela Raso
- Wei WeiWWWei Wei
- Ignacio I. WistubaIWIgnacio I. Wistuba
- Jonathan M. KurieJKJonathan M. Kurie
Open Access
- 3 April 2023
- other
- Published by American Association for Cancer Research (AACR)